Pasithea Therapeutics Stock Forecast

Sell candidate since May 15, 2026 Loss -30.92%

The Pasithea Therapeutics Corp. stock price gained 7.78% on the last trading day (Monday, 22nd Jun 2026), rising from $0.500 to $0.539. During the last trading day the stock fluctuated 18.75% from a day low at $0.500 to a day high of $0.594. The price has fallen in 6 of the last 10 days and is down by -7.88% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 350 thousand more shares were traded than the day before. In total, 546 thousand shares were bought and sold for approximately $294.30 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.497 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -20.80% during the next 3 months and, with a 90% probability hold a price between $0.393 and $0.595 at the end of this 3-month period.

KTTA Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 7.78%. Further rise is indicated until a new top pivot has been found. Pasithea Therapeutics Corp. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Pasithea Therapeutics Corp. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.544 and $0.689. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Pasithea Therapeutics Corp. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.510 and $0.502. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Pasithea Therapeutics Corp. finds support just below today's level at $0.510. If this is broken, then the next support from accumulated volume will be at $0.502 and $0.500.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0938 between high and low, or 18.75%. For the last week, the stock has had daily average volatility of 11.79%.

Pasithea Therapeutics Corp. is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KTTA) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Pasithea Therapeutics Corp. to open at $0.544, and during the day (based on 14 day Average True Range), to move between $0.514 and $0.564, which gives a possible trading interval of +/-$0.0499 (+/-9.70%) up or down from last closing price. If Pasithea Therapeutics Corp. takes out the full calculated possible swing range there will be an estimated 9.70% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.560 (3.92%) than the support at $0.510 (5.36%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Pasithea Therapeutics Corp. stock A Buy?

Pasithea Therapeutics Corp. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.237 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $0.544 ( 1.01%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk